Pharmacist Follow-up, a Qualitative Study of Patient Experience
Recruitment status was Active, not recruiting
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | April 30, 2010 | ||||||||
| Last Updated Date | May 26, 2010 | ||||||||
| Start Date ICMJE | March 2010 | ||||||||
| Estimated Primary Completion Date | July 2010 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE |
Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients [ Time Frame: 3 months or 1 year ] [ Designated as safety issue: No ] In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients' experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings. Outcomes will be presented as overall themes touched by the informants. |
||||||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||||||
| Change History | Complete list of historical versions of study NCT01131715 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Pharmacist Follow-up, a Qualitative Study of Patient Experience | ||||||||
| Official Title ICMJE | Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience. | ||||||||
| Brief Summary | A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure. |
||||||||
| Detailed Description | Not Provided | ||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | Not Provided | ||||||||
| Target Follow-Up Duration | Not Provided | ||||||||
| Biospecimen | Not Provided | ||||||||
| Sampling Method | Non-Probability Sample | ||||||||
| Study Population | Patients included in the study "Pharmacist follow-up of patients with CHD". |
||||||||
| Condition ICMJE |
|
||||||||
| Intervention ICMJE | Not Provided | ||||||||
| Study Group/Cohort (s) | Study group
Patients who are included in the pharmacist follow-up procedure |
||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Active, not recruiting | ||||||||
| Enrollment ICMJE | 4 | ||||||||
| Estimated Completion Date | July 2010 | ||||||||
| Estimated Primary Completion Date | July 2010 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria
|
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years to 80 Years | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||
| Location Countries ICMJE | Norway | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT01131715 | ||||||||
| Other Study ID Numbers ICMJE | SHAN-002 | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| Responsible Party | Lars Smaabrekke, University of Tromsø | ||||||||
| Study Sponsor ICMJE | Hospital Pharmacy of North Norway Trust | ||||||||
| Collaborators ICMJE | University of Tromso | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | Hospital Pharmacy of North Norway Trust | ||||||||
| Verification Date | May 2010 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||